Article Information
History
- December 7, 2021.
Article Versions
- Version 1 (May 17, 2021 - 11:07).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jéromine Klingler1,2,
- Gregory S. Lambert1,
- Vincenza Itri1,
- Sean Liu1,
- Juan C. Bandres1,2,
- Gospel Enyindah-Asonye1,
- Xiaomei Liu1,2,
- Viviana Simon1,3,5,6,
- Charles R. Gleason3,
- Giulio Kleiner3,
- Hsin-Ping Chiu3,
- Chuan-Tien Hung3,
- Shreyas Kowdle3,
- Fatima Amanat3,4,
- Benhur Lee3,
- Susan Zolla-Pazner1,3,
- Chitra Upadhyay1 and
- Catarina E. Hioe1,2,3,*
- 1Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 2James J. Peters VA Medical Center, Bronx, NY, USA
- 3Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 4Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 5Department of Pathology, Molecular and Cell Based Medicine Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 6Global Health and Emerging Pathogen Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- ↵*Correspondence:
catarina.hioe{at}mssm.edu, catarina.hioe{at}va.gov
Posted December 07, 2021.
Detection of Antibody Responses against SARS-CoV-2 in Plasma and Saliva from Vaccinated and Infected Individuals
